Press ReleasesLupin Receives FDA Approval for Generic Klor-Con® Extended-Release Tablets August 10, 2016Read more
Press ReleasesLupin Acquires Branded Product Portfolio from Shionogi in Japan August 2, 2016Read more
Press ReleasesLupin Receives Tentative Approval for Generic Lexiva® Tablets, 700 mg from US FDA July 27, 2016Read more
Press ReleasesUS FDA Audit at Lupin’s Dabhasa Facility, 29th June – 06th July 2016 July 8, 2016Read more
Press ReleasesLupin Receives FDA Approvals for Generic Vfend® Tablets 50mg, 200mg & Vfend® Oral Suspension, 40 mg/mL June 6, 2016Read more